These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19451331)

  • 1. Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester.
    Mallewa JE; Higgins SP; Garbett S; Saxena N; Vilar FJ
    Int J STD AIDS; 2009 Jun; 20(6):425-6. PubMed ID: 19451331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk factors associated with antiretroviral therapy].
    Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV and increased risk of cardiovascular diseases.
    Das S
    Sex Health; 2005; 2(4):219-21. PubMed ID: 16402668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment.
    Steinhart CR; Emons MF
    AIDS Read; 2004 Feb; 14(2):86-90, 93-5. PubMed ID: 14997864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic complications of antiretroviral therapy.
    Sweet DE
    Top HIV Med; 2005; 13(2):70-4. PubMed ID: 16082057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic complications of HIV therapy in children.
    McComsey GA; Leonard E
    AIDS; 2004 Sep; 18(13):1753-68. PubMed ID: 15316336
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular diseases in people with HIV.
    Highleyman L
    BETA; 2002; 15(3):10-22. PubMed ID: 12765129
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-associated and antiretroviral-induced hyperlipidaemia: an update.
    Mauss S
    J HIV Ther; 2003 May; 8(2):29-31. PubMed ID: 12838161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and skeletal complications of HIV infection: the price of success.
    Morse CG; Kovacs JA
    JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.
    Tanwani LK; Mokshagundam SL
    South Med J; 2003 Feb; 96(2):180-8; quiz 189. PubMed ID: 12630645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and cardiovascular disease.
    Hemkens LG; Bucher HC
    Eur Heart J; 2014 Jun; 35(21):1373-81. PubMed ID: 24408888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controversies and future of the approach to cardiovascular disease in HIV patients].
    Bernardino de la Serna JI; Arribas López JR
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():48-53. PubMed ID: 20172415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapine.
    Podzamczer D
    AIDS Rev; 2013; 15(4):195-203. PubMed ID: 24192600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
    Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
    Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of morphologic changes associated with antiretroviral use in HIV-infected patients.
    Wohl DA; Brown TT
    J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S93-S100. PubMed ID: 18725818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on cardiovascular complications in HIV infection.
    Currier JS
    Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.